Clinical trial
A Study of Intermittent Doses of CERC-301 in MDD
NCT02459236
Study timeline
Study start (unknown)2015-06-01Date precision: month
Registry last updated2017-09-28
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Major Depressive Disorderunresolved
Interventions
Sponsors & collaborators
Avalo Therapeutics, Inc.lead sponsor
Mapped research locations
New YorkNew York, United States1ChicagoIllinois, United States1PortlandOregon, United States1RochesterNew York, United States1MemphisTennessee, United States1Newport BeachCalifornia, United States1AllentownPennsylvania, United States1Staten IslandNew York, United States1BellevueWashington, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02459236 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.